UK Scientists Developing Ebola Vaccine That Could Be Ready for Trials in Months The World Health Organization's (WHO) upgraded risk assessment for the Democratic Republic of Congo has elevated the threat level from "high" to "very high.
" Amidst this dire situation, scientists at Oxford University are racing against time to develop a vaccine against the Bundibugyo strain of Ebola.
This vaccine could potentially be ready for clinical trials in just two to three months. The current outbreak is both tragic and unprecedented, with 750 suspected cases and 177 deaths reported so far.